Albarico, Virgilio P.

HRN: 25-30-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/15/2024
06/15/2024
IV
4.5g
Loading Dose
AGE, Amoebiasis
Waiting Final Action 
06/15/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/15/2024
06/22/2024
IV
2.25g
Every 6 Hours
Amoebiasis
Waiting Final Action 
06/15/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/15/2024
06/22/2024
IV
800mg
Every 8 Hours
Amoebiasis
Waiting Final Action 
06/18/2024
MUPIROCIN 2%, 15G (TUBE)
06/18/2024
06/25/2024
INTRADERMA
Apply To Affected Area
BID
For HD
Waiting Final Action 
06/18/2024
MUPIROCIN 2%, 15G (TUBE)
06/18/2024
06/25/2024
INTRADERMA
Apply To Affected Area
BID
For HD
Waiting Final Action 
06/18/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
06/18/2024
06/18/2024
IV
80mg
1 Dose
For HD Prophylaxis
Waiting Final Action 
06/18/2024
RIFAXIMIN 200MG (TAB)
06/18/2024
06/25/2024
PO
200mf
TID
For HD Prophylaxis
Waiting Final Action 
06/19/2024
METRONIDAZOLE 500MG (TAB)
06/19/2024
06/25/2024
PO
500 Mg
Tid
Amebiasis
Waiting Final Action 
06/19/2024
CEFTRIAXONE 1G (VIAL)
06/19/2024
06/25/2024
IV
2 Grams
OD
Sepsis
Waiting Final Action 
06/20/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
06/20/2024
06/20/2024
IJ CATH
40 Mg
Now
Ckd
Waiting Final Action 
06/20/2024
CIPROFLOXACIN 500MG (TAB)
06/20/2024
06/26/2024
ORAL
500 Mg
BID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: